SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-013357
Filing Date
2024-10-17
Accepted
2024-10-17 06:01:22
Documents
18
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K capr-20241016x8k.htm   iXBRL 8-K 45677
2 EX-1.1 capr-20241016xex1d1.htm EX-1.1 301971
3 EX-5.1 capr-20241016xex5d1.htm EX-5.1 15282
4 EX-99.1 capr-20241016xex99d1.htm EX-99.1 13475
5 GRAPHIC capr-20241016xex5d1002.jpg GRAPHIC 4308
6 GRAPHIC capr-20241016xex99d1001.jpg GRAPHIC 5626
  Complete submission text file 0001558370-24-013357.txt   572894

Data Files

Seq Description Document Type Size
7 EX-101.SCH capr-20241016.xsd EX-101.SCH 3258
8 EX-101.LAB capr-20241016_lab.xml EX-101.LAB 15269
9 EX-101.PRE capr-20241016_pre.xml EX-101.PRE 9657
20 EXTRACTED XBRL INSTANCE DOCUMENT capr-20241016x8k_htm.xml XML 4728
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 241375800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)